| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/30/2008 | CN100384475C Preparation method of magnetic guiding anticancer medicine |
| 04/30/2008 | CN100384472C Antigen-specific lgE antibody production inhibitors |
| 04/30/2008 | CN100384459C Use of pulse-activating injection in preparing synergetic medicine for treating tumor |
| 04/30/2008 | CN100384436C Parenteral cisplatin emulsion |
| 04/30/2008 | CN100384424C Synergistic methods and compositions for treating cancer |
| 04/30/2008 | CN100384419C Epothilone slow-release implanting composition and use |
| 04/30/2008 | CN100384415C Preparation method of magnetic nanometer granule containing mitocin-C |
| 04/30/2008 | CN100384412C Methods and compositions for inhibiting 5 'alpha'-reductase activity |
| 04/30/2008 | CN100384409C Use of triethylene-tetramine as antitumour auxiliary drug |
| 04/30/2008 | CN100384399C Temperature controllable heat therapeutic embolizing sponge powder an its preparation process |
| 04/29/2008 | US7365197 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 04/29/2008 | US7365191 immunology; antitumor agents; viricides; anticancer agents; antiinflammatory agents; oligosaccharde containing glucose, galactose, mannose |
| 04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365169 T-bet antibodies |
| 04/29/2008 | US7365159 Plasminogen fragments containing kringle region domains having anti-angiogenic activity and terned angiostatin protein. The plasminogen fragments of the present invention may be used for the treatment of angiogenesis-dependent diseases such as |
| 04/29/2008 | US7365155 Immunoregulator |
| 04/29/2008 | US7365089 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/29/2008 | US7365081 Antitumor agents |
| 04/29/2008 | US7365066 Pyrazolopyridine derivatives as pharmaceutical agents |
| 04/29/2008 | US7365065 Antigonadotrophins; Breast and prostate cancer, endometriosis and benign prostate hyperplasia; regulation of fertility; in-vitro fertilisation; oral administration; inexpensive; 3-Amino-4-chloro-N-[4-chloro-5-(2,3-dihydro-benzo[1,4]oxazine-4-carbonyl)-thiophen-3-ylmethyl]-N-methyl-benzenesulfonamide |
| 04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/29/2008 | US7365054 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 04/29/2008 | US7364919 Immobilization carbohydrates; calibration; diagnosis; antiinflammatory agents, bactericides |
| 04/29/2008 | US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 04/29/2008 | US7364741 Peptides of human Papilloma virus for use in human T cell response inducing compositions |
| 04/29/2008 | US7364730 Human K+ channel and prognosing applications thereof |
| 04/29/2008 | US7364729 Method of inducing a CTL response |
| 04/29/2008 | US7364726 Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine |
| 04/29/2008 | US7364724 Recombinant super-compound interferon |
| 04/29/2008 | CA2370098C Human beta-trcp protein |
| 04/29/2008 | CA2343204C Arylsulfonanilide ureas |
| 04/29/2008 | CA2302445C New taxane derivatives |
| 04/29/2008 | CA2259960C Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression |
| 04/29/2008 | CA2177952C Nucleosides and oligonucleotides containing boron clusters |
| 04/29/2008 | CA2120353C Cell cycle controlling compositions and methods of using same |
| 04/27/2008 | CA2586614A1 Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents |
| 04/27/2008 | CA2571805A1 Tissue targeted antigenic activation of the immune response to cancers |
| 04/24/2008 | WO2008048577A1 Methods of using 4-phenylaminoquinolines as topical non-steroidal antiinflammatory compounds |
| 04/24/2008 | WO2008047948A1 Block copolymer for drug complex and pharmaceutical composition |
| 04/24/2008 | WO2008047925A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | WO2008047914A1 Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | WO2008047831A1 Jak inhibitor |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047723A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/24/2008 | WO2008047574A1 Sensitizer for anticancer agent |
| 04/24/2008 | WO2008047544A1 Diaryl ketimine derivative |
| 04/24/2008 | WO2008047473A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 04/24/2008 | WO2008047307A1 Pyrido [2, 3-d] pyrimidines and their use as kinase inhibitors |
| 04/24/2008 | WO2008047082A2 Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one |
| 04/24/2008 | WO2008046985A1 Incorporation of active molecules into microalga |
| 04/24/2008 | WO2008046982A2 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7 |
| 04/24/2008 | WO2008046909A1 The histone deacetylase inhibitor helminthosporium carbonum toxin for suppressing malignant qualities of neuroblastoma cells |
| 04/24/2008 | WO2008046802A1 Phenylacetamides useful as protein kinase inhibitors |
| 04/24/2008 | WO2008046649A1 Rspondins as modulators of angiogenesis and vasculogenesis |
| 04/24/2008 | WO2008046529A1 Treatment of chemotherapy- or radiotherapy-resistant tumors using an l1 interfering molecule |
| 04/24/2008 | WO2008046459A1 Treatment of chemotherapy- or radiotherapy-resistant tumors using an l1 interfering molecule |
| 04/24/2008 | WO2008046407A2 Use of deuterium dioxide for treating hyperproliferative skin diseases |
| 04/24/2008 | WO2008046307A1 Method for inhibiting cancer using arsenic trioxide |
| 04/24/2008 | WO2008046299A1 Method for inhibiting cancer using arsenic trioxide |
| 04/24/2008 | WO2008046251A1 Fusion proteins containing n domain of human calreticulin and human papillomavirus type 16 e6 or e7 and uses thereof |
| 04/24/2008 | WO2008046242A1 The novel quinazoline derivatives,preparation methods and uses thereof |
| 04/24/2008 | WO2008046228A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 04/24/2008 | WO2008046216A1 Kinase inhibitors and uses thereof |
| 04/24/2008 | WO2008020456A3 Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 04/24/2008 | WO2008020206A3 Fused thiophene derivatives as mek inhibitors |
| 04/24/2008 | WO2008016660A3 Imidazoacridine compounds for treating leukemias |
| 04/24/2008 | WO2008015139A3 Inhibitors of zinc proteases thioaryl substituted and their use |
| 04/24/2008 | WO2008012695A3 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells |
| 04/24/2008 | WO2008012534A3 Retinoids and small molecules as nrf2 antagonists for use in the treatment of diseases associated with abnormal cell proliferation |
| 04/24/2008 | WO2008011080A3 Benzo(d) isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine |
| 04/24/2008 | WO2008001166A3 Process for synthesis of glycomimicking cationic amphiphiles |
| 04/24/2008 | WO2008000881A9 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 04/24/2008 | WO2007149730A3 Inhibitors of akt (protein kinase b) |
| 04/24/2008 | WO2007112754A3 Pharmaceutical compositions comprising anti-mirna antisense oligonucleotides |
| 04/24/2008 | WO2007084162A3 Sirtuin inhibiting compounds |
| 04/24/2008 | WO2007075870A3 Processes for taxane derivatives and intermediates useful therein |
| 04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 04/24/2008 | US20080096947 Polyvinylpyrrolidone or cyclodextrin as a builder, and polysorbate as a wetting agent, are dissolved with imexon in an organic solvent, preferably dimethyl sulfoxide, and lyophylized; lyophilisates are dissolved in aqueous propylene glycol; improved storage stability |
| 04/24/2008 | US20080096946 Tetramethylation of 3,5-di(cyanomethyl)toluene, oxidation of the 1-methyl group to form an aldehyde, conversion to a Boc-protected hydrazone, reduction to a Boc-protected hydrazine, salt formation, conversion to anastrozole; industrial scale, high yield and purity; anticarcinogenic agent; breast cancer |
| 04/24/2008 | US20080096920 3-{4-[Bis-(quinolin-8-ylcarbamoylmethyl)-amino]-phenyl}-N-hydroxy-acrylamide; 4-(2-Hydroxycarbamoyl-vinyl)-N,N-bis-phenylcarbamoylmethyl-benzamide; useful in treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, and neurdegenerative disorders |
| 04/24/2008 | US20080096901 Aminotriazole compounds useful as inhibitors of protein kinases |
| 04/24/2008 | US20080096899 N-Phenyl-2-Pyrimidine-Amine Derivatives and Process for the Preparation Thereof |
| 04/24/2008 | US20080096897 water soluble; lower toxicity by photosensitization; anticancer; antitumor; antiinflammatory; arthritis; osteoporosis; ocular abnormal angiogenesis; multiple sclerosis, asthma, atherosclerosis |
| 04/24/2008 | US20080096889 Histone Deacetylases Inhibitors |
| 04/24/2008 | US20080096887 Benzene, Pyridine, and Pyridazine Derivatives |
| 04/24/2008 | US20080096881 Quinazoline Derivatives |
| 04/24/2008 | US20080096880 Use of imidazo[1,2,4]triazinones which are inhibitors of cGMP-metabolizing phosphodiesterases (PDE I, II and V) to treat cardiovascular disorders, urogenital disorders, prostate hyperplasia, ocular disorders such as glaucoma, optic neuropathy, diabetic gastroparesis, dementia |
| 04/24/2008 | US20080096879 More potent analogs of FR901464 from Pseudomonas sp. No. 2663 culture and chemical synthesis; anticancer agents; intermediates |
| 04/24/2008 | US20080096868 [1-(4-methoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-o-tolyl-amine for example; protein tyrosine kinase inhibitors; anticancer agents |
| 04/24/2008 | US20080096864 Partially imatinib-resistant tumors; synergistic; combined packaging; oral administration |
| 04/24/2008 | US20080096861 Chemical Compounds |
| 04/24/2008 | US20080096854 Orally administering edible oil homogenized with edible wax and a sterol comprising stigmasterol, campesterol, p-sitosterol, chalinosterol, clionasterol, brassicasterol, alpha -spinasterol, daucosterol, desmosterol, and poriferasterol to treat colorectal, stomach, and/or esophagus cancer |
| 04/24/2008 | US20080096849 Administering balsalazide with food increases bioavailability of balsalazide and metabolites 5-aminosalicylic acid and N-acetyl-5-aminosalicylic acid; label on container recommends to take drug with food; inflammatory bowel disease, radiation enteritis, colon cancer; gastrointestinal disorders |
| 04/24/2008 | US20080096848 Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of Apoptosis |
| 04/24/2008 | US20080096846 Ruthenium complexes with ligands that have a longer hydrolysis time such as azide, isothiocyanate, pyridines, thiolates; thought to bind to DNA after hydrolysis for antitumor effect; pharmacokinetics; ruthenium complex with biphenyl, ethylenediamine, azide and hexafluorophosphide for example |
| 04/24/2008 | US20080096834 Administering a nucleic acid encoding a trout E-domain peptide or somatomedin as antiproliferative, anticarcinogenic and/or antitumor agent in mammals or fish |
| 04/24/2008 | US20080096833 Diagnostic drugs and kits; coded for human proto-oncogene Pim-3, an antibody specific thereto; short interence RNA; genetic engineering |